Revision of the positive predictive value of IgM anti-Toxoplasma antibodies as an index of recent infection

New Microbiologica

Volumn 31, Issue 1, 2008, Pages 105-111

  De Paschale, Massimo ^a,b   Agrappi, Carlo ^a   Belvisi, Luisa ^a   Cagnin, Debora ^a   Cerulli, Teresa ^a   Clerici, Pierangelo ^a   Mirri, Paola ^a   Manco, Maria Teresa ^a   Cavallari, Serena ^a   Viganò, Egidio Franco ^a  

^a Hospital of Legnano   (Italy)

^b Ospedale Civile di Legnano   (Italy)

Author keywords

IgM anti Toxoplasma; Predictive value; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; AGED; ANIMAL; ARTICLE; BLOOD; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PARASITOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; TOXOPLASMA; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 41049098051     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ADES A.E., PARKER S., GILBERT R., TOOKEY P.A., BERRY T., HJELM M., WILCOX A.M., CUBITT D., PECKHAM C.S. (1993). Maternal prevalence of Toxoplasma anti-body based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol. Infect. 110, 127-133.
2. ALLAIN J.P., PALMER C.R., PEARSON G. (1998). Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK. J. Infect. 36, 189-196.
3. ANCELLE, T., GOULET V., TIRAD-FLURY V., BARIL L., DU MAZAUBRUN C., THULLIEZ P.H., WCISLO M., CARM B. (1996). La toxoplasmose chez la femme enceinte en France en 1995. Résultats d'une enquête nationale périnatale. BEH. 51, 227-229.
4. DANNEMANN B.R., VAUGHAN W.C., THULLIEZ P., REMINGTON J.S. (1990). Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J. Clin. Microbiol. 28, 1928-1933.
5. DIZA E., FRANTZIDOU F., SOULIOU E., ARVANITIDOU M., GIOULA G., ANTONIADIS A (2005). Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clin. Microbiol. Infect. 11, 719-723.
6. GARRY D.J., ELIMINIAN A., WIENCEK V., BAKER D.A. (2005). Commercial laboratory IgM testing for Toxoplasma gondii in pregnancy: a 20-year experience. Infect. Dis. Obstet. Gynecol. 13, 151-153.
7. GILBERT R.E. (2000). Epidemiology of infection in pregnant women. In: Petersen, E., Amboise-Thomas, P. Eds, Congenital toxoplasmosis: scientific background, clinical management and control. Springer-Verlag, Paris. (France).
8. GRAS L., GILBERT R.E. ADES A.E., DUNN D.T. (2001). Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Intern. J. Epidemiol. 30, 1309-1313.
9. GRAS L., GILBERT R.E., WALLON M., PEYRON F., CORTINA-BORJA M. (2004). Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol. Infect. 132, 541-548.
10. GUTIERREZ-ZUFIAURRE N., SANCHEZ- HERNANDEZ J., MUNOZ S., MARIN R., DELGADO N., SAENZ M.C., MUNOZ-BELLIDO J.L., GARCIA-RODRIGUEZ J.A. (2004). Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm. Infecc. Microbiol. Clin. 22, 512-516.
11. HOLLIMAN R.E., BONE G.P., JOHNSON J.D. (1996). The exclusion of recent onset Toxoplasma infection in patients with prolonged IgM response by the measurement of IgA and avidity. Serodiag Immunother Infect. Dis. 8, 57-59.
12. JENUM P.A., STRAY-PEDERSEN B., MELBY K.K., KAPPERUD G., WHITELAW A., ESKILD A., ENG J. (1998). Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J. Clin. Microbiol. 36, 2900-2906.
13. JONES J.L., DIETZ V.J., POWER M., LOPEZ A., WILSON M., NAVIN T.R., GIBBS R., SCHULKIN J. (2001). Survey of obstetrician-gynecologists in the United States about toxoplasmosis. Infect. Dis. Obstet. Gynecol 9, 23-31.
14. JONES J.L., KRUSZON-MORAN D., WILSON M. (2003). Toxoplasma gondii infection in the Unites States, 1999-2000. Emerg. Infect. Dis. 9, 1371-1374.
15. JOYNSON D.H.M., GUY E.C. (2001). Laboratory diagnosis of Toxoplasma infection. In: Joynson, D.H.M., Wreghitt, T.G. Eds, Toxoplasmosis: a comprehensive clinical guide. Cambridge University Press, Cambridge (UK). 296-318.
16. LAPPALAINEN M., KOSKELA P., KOSKINIEMI M., AMMALA P., HIILESMAA V., TERAMO K., RAIVIO K.O., REMINGTON J.S., HEDMAN K. (1993). Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J. Infect.Dis. 167, 691-697.
17. LEBECH M., LARSEN S.Q., PETERSEN E. (1993). Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand. J. Infect. Dis. 25, 751-756.
18. LECOLIER B., PUCHEU B. (1993). Value of the study of IgG avidity for the diagnosis of toxoplasmosis. Pathol. Biol. (Pans). 41, 155-158.
19. LIESENFELD O., PRESS C., FLANDERS R., RAMIREZ R., REMINGTON J.S. (1996). Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M Toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. J. Clin. Microbiol. 34, 2526-2530.
20. MCCABE R.E., BROOKS R.G., DORFMAN R.F., REMINGTON J.S. (1987). Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev. Infect. Dis. 9, 754-774.
21. MONTOYA J.G., REMINGTON J.S. (1995). Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin. Infect. Dis. 20, 781-790.
22. MUNOZ BATET C., GUARDIA LLOBET C., JUNCOSA MORROS T., VINAS DOMENECH L., SIERRA SOLER M., SANFELIU SALA I., BOSCH MESTRES J., DOPICO PONTE E., LITE LITE J., MATAS ANDREU L., JUSTE SANCHEZ C., BARRANCO ROMEU M. (2004). Toxoplasmosis and pregnancy. Multicenter study of 16,632 pregnant women in Barcelona. Med. Clin. (Barc). 123, 12-16.
23. PETERSSON K., STRAY-PEDERSEN B., MALM G., FORSGREN M., EVENGARD B. (2000). Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet. Gynecl. Scand. 79, 824-829.
24. PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US), FOOD AND DRUG ADMINISTRATION. (1997). FDA Public Health Advisory: limitations of toxoplasmosis IgM commercial test kits (letter). Washington: Department of Health and Human Services (US).
25. REMINGTON J.S., MCLEOD R., THULLIEZ P., DESMONTS G. (2001). Toxoplasmosis. In: Remington, J.S., Klein, J. Eds, Infectious diseases of the foetus and newborn infant. Fourth Edition. W.B. Saunders, Philadelphia (USA). 205-346.
26. SABIN A.B., FELDMAN H.A. (1948). Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science. 108, 660-663.
27. SEQUELA J.P. (1982). Cinétique des anticorps IgA, IgG, IgM dans la toxoplasmose. Lyon Med. 248, 21-23.
28. STEPICK-BIEK P., THULLIEZ P., ARAUJO F.G., REMINGTON J.S. (1990). IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J. Infect. Dis. 162, 270-273.
29. STRONATI M., LANZARINI P., MERONI V., RONDINI G. (1996). Toxoplasmosi: prevenzione, diagnosi e terapia nella donna in gravidanza, nel feto e nel neonato. Riv. Ital. Ped. 22, 145-153.
30. WONG S.Y., HAJDU M.P., RAMIREZ R., THULLIEZ P., MCLEOD R., REMINGTON J.S. (1993). Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J. Clin. Microbio. 31, 2952-2959.